Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study.

Saved in:

Bibliographic Details
Title:	Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study.
Authors:	Oldgren, Jonas¹ (AUTHOR) jonas.oldgren@ucr.uu.se, Laurila, Sanna^2,3,4 (AUTHOR), Åkerblom, Axel¹ (AUTHOR), Latva‐Rasku, Aino³ (AUTHOR), Rebelos, Eleni³ (AUTHOR), Isackson, Henrik¹ (AUTHOR), Saarenhovi, Maria³ (AUTHOR), Eriksson, Olof⁵ (AUTHOR), Heurling, Kerstin⁵ (AUTHOR), Johansson, Edvin⁵ (AUTHOR), Wilderäng, Ulrica⁶ (AUTHOR), Karlsson, Cecilia⁶ (AUTHOR), Esterline, Russell⁷ (AUTHOR), Ferrannini, Ele⁸ (AUTHOR), Oscarsson, Jan⁶ (AUTHOR), Nuutila, Pirjo³ (AUTHOR)
Source:	Diabetes, Obesity & Metabolism. Jul2021, Vol. 23 Issue 7, p1505-1517. 13p.
Database:	Academic Search Ultimate

Description
ISSN:	14628902
DOI:	10.1111/dom.14363